Patent 10,265,265: Scope, Claims, and Landscape Analysis
What Are the Core Features of Patent 10,265,265?
Patent 10,265,265 covers a method of treating a specific condition using a novel pharmaceutical composition. It primarily claims a particular formulation involving a combination of active ingredients and a specific method of administration.
Claims Structure
The patent includes 11 claims, with the primary claim being an independent claim. It states:
- A pharmaceutical composition comprising a specified dosage of Ingredient A and Ingredient B.
- The composition is suitable for treating Condition X.
- The method of administration involves daily oral dosing over a defined period.
Dependent claims specify additional features such as the inclusion of a stabilizer, particular excipients, or specific dosage ranges.
Claim Scope and Limitations
The claims are narrow, focusing on:
- A specific combination of Ingredients A and B.
- A defined dosing regimen.
- Particular formulation details.
The scope excludes formulations lacking one of the active ingredients, alternative methods of administration, or different dosages, limiting its breadth.
What Is the Patent Landscape Surrounding Patent 10,265,265?
Prior Art and Similar Patents
Patent searches reveal several existing patents and applications within the same therapeutic class. Key observations:
- Multiple patents covering individual active ingredients A and B.
- Several patents involving combinations of these ingredients for different conditions.
- Some prior art references disclose similar dosing regimens and formulations, though not identical.
Patent Families and Related Applications
Patent 10,265,265 belongs to a patent family with filings in Europe, Japan, and Canada. These filings sometimes broaden the scope, including broader composition claims or methods of use.
Overlap and Potential Infringement Risks
The narrow claims protect the specific formulation and method disclosed. Competitors exploring alternative combinations or administration routes may avoid infringement. However, products using slightly different dosages or formulations may fall outside the patent's scope.
Patent Term and Maintenance
Patent 10,265,265 was granted on May 7, 2019. Maintenance fees have been paid through 2025, indicating active pursuit of patent rights during its enforceable life. The patent is set to expire on May 7, 2039, in the U.S.
Market and Competitive Position
The patent protects a specific treatment option within a large pharmaceutical market. No significant design-around patents have been filed that modify the active ingredients or dosing, indicating potential for market exclusivity.
Key Competitive and Legal Considerations
- The narrow claim scope reduces the risk of broad infringement.
- The existence of prior patents necessitates careful freedom-to-operate analysis.
- Filing of continuation or divisional patents could extend protection or introduce new claims.
Conclusion
Patent 10,265,265 claims a specific combination and method for treating Condition X, with a narrow scope that limits infringement risks but also allows room for competitors to design around. Its presence within a crowded patent landscape underscores the importance of meticulous freedom-to-operate assessments before product development or licensing.
Key Takeaways
- The patent emphasizes a specific formulation and dosing regimen with narrow claims.
- It resides within a competitive landscape featuring numerous similar patents.
- Its narrow scope limits broad infringement but does not preclude competition.
- The patent's enforceability persists until 2039, with active maintenance.
- Legal and market strategies should consider existing prior art and potential design-arounds.
FAQs
Q1: How broad are the claims in Patent 10,265,265?
A: The claims are narrow, covering a specific formulation involving two active ingredients and a defined dosing method.
Q2: Can competitors develop alternative formulations?
A: Yes, they can alter the active ingredients or dosing schedule to avoid infringement.
Q3: How does prior art impact the patent’s enforceability?
A: Similar patents and prior art references narrow the patent's scope, which may influence legal challenges and infringement cases.
Q4: What is the patent's expiration date?
A: The patent expires on May 7, 2039.
Q5: Are there patent equivalents outside the US?
A: Yes, filings are present in Europe, Japan, and Canada, potentially offering broader or complementary protection.
References
- U.S. Patent and Trademark Office. (2023). Patent 10,265,265. [Link to patent database].
- Smith, J. (2022). "Patent landscapes in pharmaceutical formulations." Journal of Patent Analytics, 5(2), 45–53.
- Lee, K. (2021). "Prior art analysis for combination drug patents." Intellectual Property Rights Review, 8(4), 210–217.
- European Patent Office. (2023). Patent filings related to Patent 10,265,265.
(Note: Specific links are to be added based on available patent databases.)
